Indian pharmaceutical and healthcare firms are set for a significant fundraising push, aiming to garner 12,000-13,000 crore through IPOs in the coming months. Approximately fifteen companies are expected to enter the primary market, with fertility and women's health segments particularly in focus.
Mumbai bond market awaits the government's borrowing calendar. Traders are cautious before the monetary policy review. They anticipate details on the Centre's H2 borrowing. The market expects changes in long-term bond issuance. RBI's reallocation strategy is also under scrutiny. Experts suggest measures to address yield curve distortions. The focus is on rebalancing the borrowing calendar.
Continuum Green Energy Holdings will acquire the remaining 26% stake from Clean Energy Investing (CEIL), marking Morgan Stanley Infrastructure Partners' exit after a decade. This acquisition consolidates control under founders Vikash Saraf and Arvind Bansal ahead of Continuum's planned 3,650 crore IPO. The IPO proceeds will be used for debt repayment, general corporate purposes, and investments in subsidiaries.
Real estate stocks are experiencing a downturn, extending losses for the third consecutive session due to concerns about slowing demand and profit-taking after a significant rally. The realty index has underperformed the Nifty, with several key stocks like Godrej Properties and DLF seeing notable declines. Analysts anticipate potential further drops amid sluggish demand and strong supply.
Several mutual funds, including Axis and HDFC, now offer constant maturity index funds tracking the CRISIL-IBX Financial Services 3-6 Month Debt Index, presenting an alternative to short-term bank deposits. These funds invest in short-term debt instruments issued by financial institutions, offering indicative yields of 6-6.4%, significantly higher than typical bank deposit rates.
Indian stock markets faced a fourth day of losses. This was due to worries about possible economic actions from the United States. The NSE Nifty and BSE Sensex both declined. H-1B visa concerns also affected market sentiment. Foreign investors sold shares, while domestic institutions bought. Experts suggest that market dips could be buying opportunities.
